This site is intended for Healthcare Professionals only.

Avril Chester to join RPS as Chief Technology Officer from June

Date:

Share post:

The Royal Pharmaceutical Society (RPS) has appointed Avril Chester as its new Chief Technology Officer.

Avril joins the RPS in June and will be accountable for the development and implementation of the RPS technology and digital strategy. Last year RPS launched a new platform for the Pharmaceutical Journal and plans to develop more digital products and services for our members and customers.

In her new role, Avril will have responsibility for executive leadership of all the technology functions, including technical architecture, software development, operations and product delivery. Avril will report directly to the Chief Executive, Paul Bennett, and joins the Society’s Executive team in June.

Avril is currently Chief Technology Officer at the Royal Institute of British Architects. Alongside that, she is an award-winning technology entrepreneur, author, podcast host and founder of a cancer charity. She was also finalist for CTO of the Year at the Women in IT awards 2022.

Paul Bennett, CEO said: “I am delighted that Avril will be joining our Executive team and leading our technology function and our digital strategy. We have a strong technology team within RPS and Avril’s appointment strengthens that further as she brings great energy, drive, experience and enthusiasm with her and my colleagues and I very much look forward to working closely with her as we further develop our technological capability”

Commenting on her appointment Avril said: “It is a real honour to support our incredible pharmacists and pharmaceutical scientists and I am over the moon to have this opportunity to join the Royal Pharmaceutical Society. Technology has and continues to impact our lives, especially in healthcare and medicine. The RPS already embraces the technology evolution and I look forward to continuing this great work and push even more digital boundaries to champion and support the profession”.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Ban on sale and supply of puberty blockers further extended

The health secretary has expressed the intention to make the ban on puberty blockers permanent The UK government...

Why we need awareness weeks like National Self-Care Week

Trevor Gore, treasurer and trustee of the Self-Care Forum, explains how pharmacists can help reduce preventable illnesses by...

Dr Joanne Brown receives inaugural Barnett Award at RPS Annual Conference

The Barnett Award was created last year by the RPS in memory of esteemed RPS Fellow Nina Barnett  The...

RSV infections lead to 640,000 antibiotic prescriptions a year

Around 2.1% of antibiotic prescriptions in English GPs were linked to RSV infections.  Experts suggest that the new Respiratory...